Details for Patent: 11,628,155
✉ Email this page to a colleague
Which drugs does patent 11,628,155 protect, and when does it expire?
Patent 11,628,155 protects EPSOLAY and is included in one NDA.
This patent has twelve patent family members in two countries.
Drugs Protected by US Patent 11,628,155
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Galderma Labs Lp | EPSOLAY | benzoyl peroxide | CREAM;TOPICAL | 214510-001 | Apr 22, 2022 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | TOPICAL TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA IN ADULTS 18 YEARS OF AGE AND OLDER | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,628,155
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 3130362 | ⤷ Subscribe | |||
| Canada | 3130437 | ⤷ Subscribe | |||
| Canada | 3130439 | ⤷ Subscribe | |||
| Canada | 3130441 | ⤷ Subscribe | |||
| World Intellectual Property Organization (WIPO) | 2020170029 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
